HOME Top Market Reports High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

By: marketsandmarkets.com
Publishing Date: February 2014
Report Code: BT 2227

 

Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global high content screening market is segmented on the basis of products, applications, end users, and geography. The products market is further segmented into instruments, consumables, software, and services. Based on applications, the market is divided into primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and other applications. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs). Based on geography, this market is divided into North America, Europe, Asia, and the Rest of the World (RoW).

The market is expected to witness a high growth in the forecast period. This high growth can be attributed to a number of factors such as the need for determining toxicity levels in the early stage of drug discovery pipelines. Furthermore, government bodies have extended their help in the form of investments, grants, and funds for cell-based research activities. This has provided the required stimulus for growth of this market. For instance, the German government, through BioMet network, funded the Max Planck Institute of Molecular Cell Biology and Genetics in Germany for industry-academic collaborations in Europe in the area of high content screening. Furthermore, various factors such as better informatics services and improved reagents and image analysis instruments are propelling the growth of this market. However, the major concerns of this market are greater capital investments and lack of skilled personnel for carrying out the HCS process.

North America is the largest market for HCS, followed by Europe and Asia. However, the Asian market is expected to witness a healthy growth over the next five years.

The key players in the global market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), Perkin Elmer (U.S.), GE Healthcare Lifesciences (U.K), and Merck Millipore (Germany), among others.

Scope of the Report
This research report categorizes the global high content screening market into the following segments and sub-segments:

By Product:

  • High Content Screening Instruments
    • Cell Imaging and Analysis HCS Systems
    • Flow Cytometers
  • High Content Screening Consumables
    • Reagents and Assay Kits
  • Microplates
  • Other Consumables
  • High Content Screening Software
  • High Content Screening Services

By Application:

  • Primary and Secondary Screening
  • Target Identification and Validation
  • Toxicity Studies
  • Compound Profiling
  • Other Applications

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations (CROs)

By Geography:

  • North America
  • Europe
  • Asia
  • RoW

Table Of Contents
 
1 Introduction (Page No. - 14)
   1.1 Objectives of the Study
   1.2 Report Description
   1.3 Markets Covered
   1.4 Stakeholders
   1.5 Market Scope
   1.6 Research Methodology
       1.6.1 Market Size Estimation
       1.6.2 Market Crackdown and Data Triangulation
       1.6.3 Market Share
       1.6.4 Key Data Points From Primary Sources
       1.6.5 Key Data Points From Secondary Sources

2 Executive Summary (Page No. - 25)

3 Market Overview (Page No. - 29)
   3.1 Introduction
   3.2 Market Segmentation
   3.3 Market Dynamics
       3.3.1 Drivers
             3.3.1.1 Need For Determining Level of Toxicity in the Early Stages of Drug Discovery
             3.3.1.2 Government Funding and Venture Capital Investments in Cell-Based Research Will Drive the Market Growth
             3.3.1.3 Introduction of Enhanced Informatics Solutions and Improved Image Analysis Instruments
       3.3.2 Restraints
             3.3.2.1 High Cost of High Content Screening Systems May Hinder the Market Growth
       3.3.3 Opportunities
             3.3.3.1 Contract Research Organizations Have Significant Opportunities To Provide HCS Services
             3.3.3.2 Adoption of High Content Screening For Primary Screening
             3.3.3.3 Application of High Content Screening in Personalized Medicine
             3.3.3.4 Collaborations To Increase Innovation in the HCS Market
       3.3.4 Challenges
             3.3.4.1 Shortage of Knowledgeable and Skilled Professionals For High Content Screening 
   3.4 Market Share Analysis

4 By Product Type (Page No. - 41)
   4.1 Introduction
   4.2 Instruments
       4.2.1 Cell Imaging and Analysis Systems
       4.2.2 Flow Cytometers
   4.3 Consumables
       4.3.1 Reagents & Assay Kits
       4.3.2 Microplates
       4.3.3 Other Consumables
   4.4 Software
   4.5 Services

5 By Application (Page No. - 60)
   5.1 Introduction
       5.1.1 Target Identification and Validation
       5.1.2 Primary Screening and Secondary Screening
       5.1.3 Toxicity Studies
       5.1.4 Compound Profiling
       5.1.5 Other Applications

6 By End Users (Page No. - 71)
   6.1 Pharmaceutical and Biotechnology Companies
   6.2 Academia and Government Institutes
   6.3 Contract Research Organizations (CRO)

7 Geographic Analysis (Page No. - 80)
   7.1 Introduction
   7.2 North America
   7.3 Europe
   7.4 Asia
   7.5 ROW

8 Competitive Landscape (Page No. - 103)
   8.1 Introduction
   8.2 New Product Launch
   8.3 Expansions
   8.4 Agreements, Collabarations, Partnerships
   8.5 Acquisitions

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 114)
   9.1 Becton, Dickinson and Company
   9.2 Cell Signaling Technology, Inc.
   9.3 Danaher Corporation
   9.4 Ge Healthcare (Subsidiary of General Electric Company)
   9.5 Genedata Ag
   9.6 Merck Kgaa
   9.7 Perkinelmer, Inc.
   9.8 thermo Fisher Scientific, Inc.
   9.9 Thorlabs, Inc.
   9.10 Yokogawa Electric Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.


List of Tables (50 Tables)

Table 1 Global Market, By Product Type, 20112018 ($Million)
Table 2 HCS Products Market, By Geography, 20112018 ($Million)
Table 3 The Global High Content Screening Instruments Market, By Type, 20112018 ($Million)
Table 4 HCS Instruments Market, By Geography, 20112018 ($Million)
Table 5 Cell Imaging and Analysis High Content Screening Systems Market, By Geography, 20112018 ($Million)
Table 6 HCS Flow Cytometers Market, By Geography, 20112018 ($Million)
Table 7 Global High Content Screening Consumables Market, By Type, 20112018 ($Million)
Table 8 HCS Consumables Market, By Geography, 20112018 ($Million)
Table 9 HCS Reagents and Assay Kits Market, By Geography, 20112018 ($Million)
Table 10 HCS Microplates Market, By Geography, 20112018 ($Million)
Table 11 HCS Other Consumables Market, By Geography, 20112018 ($Million)
Table 12 HCS Software Market, By Geography, 20112018 ($Million)
Table 13 HCS Services Market, By Geography, 20112018 ($Million)
Table 14 Global HCS Applications Market, By Type, 20112018 ($Million)
Table 15 HCS Applications Market, By Geography, 20112018 ($Million)
Table 16 HCS Target Identification and Validation Market, By Geography, 2011-2018 ($Million)
Table 17 HCS Primary and Secondary Screening Market, By Geography, 20112018 ($Million)
Table 18 HCS Toxicity Studies Market, By Geography, 20112018 ($Million)
Table 19 HCS Compound Profiling Market, By Geography, 20112018 ($Million)
Table 20 HCS Other Applications Market, By Geography, 20112018 ($Million)
Table 21 Global Market, By End User, 20112018 ($Million)
Table 22 HCS End Users Market, By Geography ($Million)
Table 23 Pharmaceutical and Biotechnology Companies HCS Market, By Geography, 20112018 ($Million)
Table 24 Academia and Government Institutes HCS Market, By Geography, 20112018 ($Million)
Table 25 Contract Research Organization HCS Market, By Geography, 2011-2018 ($Million)
Table 26 HCS Product Market, By Geography, 20112018 ($Million)
Table 27 North America: Market, By Product Type, 20112018 ($Million)
Table 28 North America: HCS Instruments Market, By Type, 20112018 ($Million)
Table 29 North America: HCS Consumables Market, By Type, 20112018 ($Million)
Table 30 North America: Market, By Application Type, 20112018 ($Millions)
Table 31 North America: Market, By End User, 20112018 ($Million)
Table 32 Europe: Market, By Product Type, 20112018 ($Million)
Table 33 Europe: HCS Instruments Market, By Type, 20112018 ($Million)
Table 34 Europe: HCS Consumables Market, By Type, 20112018 ($Million)
Table 35 Europe: Market, By Application Type, 20112018 ($Million)
Table 36 Europe: Market, By End User, 20112018 ($Million)
Table 37 Asia: Market, By Product Type, 20112018 ($Million)
Table 38 Asia: HCS Instruments Market, By Type, 20112018 ($Million)
Table 39 Asia: HCS Consumables Market, By Type, 20112018 ($Million)
Table 40 Asia: Market, By Application, 20112018 ($Million)
Table 41 Asia: Market, By End User, 20112018 ($Million)
Table 42 ROW: Market, By Product Type, 20112018 ($Million)
Table 43 ROW: HCS Instruments Market, By Type, 20112018 ($Million)
Table 44 ROW: HCS Consumables Market, By Type, 20112018 ($Million)
Table 45 ROW: Market, By Application, 20112018 ($Million)
Table 46 ROW: Market, By End User, 20112018 ($Million)
Table 47 New Product Launch, 20112013
Table 48 Expansions, 20112013
Table 49 Agreements, Partnerships, Collabarations, 20112013
Table 50 Acquisitions, 20112013


List of Figures (10 Figures)

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology
Figure 3 Market Crackdown & Data Triangulation Methodology For the HCS Market
Figure 4 Global Market, By Product, 20132018 ($Million)
Figure 5 HCS Market, By Geography, 20132018 ($Million)
Figure 6 Market Segmentation
Figure 7 Market Dynamics
Figure 8 Global HCS Instruments Market Share, By Key Players, 2013
Figure 9 HCS Products Market, By Geography, 2013
Figure 10 Key Growth Strategies, HCS Market, 20112013

In recent years, the adoption of high content screening in various phases of drug discovery has increased. The global was valued at $362.2 million in 2013 and is expected to reach $615.8 million by 2018, at a CAGR of 11.2%. The market is broadly classified based on products, applications, end users, and geographies.

The product market is further divided into instruments, consumables, software, and services. The instruments market is sub-divided into cell imaging and analysis systems and flow cytometers. The consumables market is further segmented into reagents and assay kits, microplates, and other consumables. The software market includes the market for image analysis and data management software. The services market includes screeningservices such as primary screening and secondary screening, services related to target identification and validation, toxicity studies, and compound profiling.

The applications market includes primary screening and secondary screening, target identification and validation, toxicity studies, compound profiling and other applications. High content screening can be applied in both primary and secondary screening, although it is extensively used for the secondary screening process. In target identification, HCS is used to identify novel targets through the screening of cellular pathways. HCS can also provide more accurate information related to drug toxicity and mode of actions that helps in further decision making and helps to drive the progress of drug discovery. The other application of HCS is in studying cell signaling pathways. The primary and secondary screening market dominated the high content screening applications market, with a market share of 50% in 2013.

The major factors driving the growth of the market include the need for determining the level of toxicity in the early stages of drug discovery pipeline, government support for cell-based research, and the introduction of enhanced informatics solutions and improved image analysis instruments. Moreover, the adoption of HCS for primary screening and its application in the development of personalized medicine are key growth opportunities in this market.

However, the high cost of the high content screening systems may hinder the growth of this market. In addition, the shortage of knowledgeable and skilled professionals for high content screening remains a major challenge for this market.

Global High Content Screening Market, by Geography, 2013

High Content Screening Market

Source: Annual Reports, SEC Filings, International Society for Advancement of Cytometry, International Society for Stem Cell Research, Society for Laboratory Automation and Screening, American Society for Cell Biology, Society of Biomolecular Imaging and Informatics, Irish National Centre for High Content Screening (INCHSA),Expert Interviews, MarketsandMarkets Analysis

The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period, followed by Europe. Over the next five years, the growth of the global market in the Asian region is likely to be centered on China, Japan, Singapore, and India. This growth will be driven by government support for the growth of innovative technologies and the rising demand for outsourcing of drug discovery services.

The major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology (U.S.), Genedata AG (Switzerland), Merck KGaA (Germany), Thorlabs, Inc. (U.S.), and Yokogawa Electric Corporation (Japan), among others

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports